Abstract
The potential role of smoking in breast cancer risk has been the subject of over 100 publications, numerous scientific reviews, and animated debate. Tobacco exposure is a well-established cause of lung cancer, and is thought to account for nearly one third of all cancer deaths. Tobacco smoke contains thousands of chemicals, many of which are known to be mammary carcinogens. Although not initially thought to be a tobacco-related cancer, over the last several decades evidence has been accumulating on the role of both active smoking and secondhand smoking in the etiology of breast cancer. The human health evidence has been systematically evaluated not only by several independent researchers but also by several expert agency panels including those of the U.S. Surgeon General, the International Agency for Research on Cancer, the California Environmental Protection Agency, and a coalition of Canadian health agencies. Although the assessments have varied with time and across reviewers, the most recent weight of the evidence has suggested a potentially casual role for active smoking and breast cancer, particularly for long-term heavy smoking and smoking initiation at an early age. The role of secondhand smoking and breast cancer is less clear, although there has been some suggestion for an increased risk for premenopausal breast cancer. Recent studies evaluating the possible modifying role of polymorphisms in genes involved in the metabolism of tobacco products, particularly NAT2, have contributed another dimension to these assessments, although to date that evidence remains equivocal.
Similar content being viewed by others
References
U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington 1964.
U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Washington: U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1982.
International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. Lyon (France): International Agency for Research on Cancer; 1986.
United States Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Diseae Control and Prevention, National Center for Chronic Disease, Prevention and Health Promotion, Office of Smoking and Health; 2010.
Collishaw NE, Boyd NF, Cantor KP, Hammond SK, Johnson KC, Millar J. Ontario Research Unit, OTRU Special Report Series. Toronto, Canada: Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk; 2009.
Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen. 2002;39:119–26.
United States Department of Health and Human Services. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health; 1986.
United States Public Health Service, Office of the Surgeon General, editor. Women and Smoking: A Report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
United States Public Health Service, Office of the Surgeon General, editor. The Health Consequences of Smoking: a Report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; 2004.
International Agency for Research on Cancer. Some Chemicals in Industrial and Consumer Products, Food Contaminants and Flavourings and Water Chlorination By-Products: Volume 100E, Personal Habits and Indoor Combustions. Lyon (France) 2012.
California Environmental Protection Agency. Health Effects of Exposure to Environmental Tobacco Smoke. Sacremento CA: California Environmental Protection Agency, Office of Environmental Health Hazard Assessment; 1997.
California Environmental Protection Agency. Proposed identification of environmental tobacco smoke as a toxic air contaminant. Sacramento: California Environmental Protection Agency, Office of Environmenatal Health Hazard Assessment; 2005.
Miller MD, Marty MA, Broadwin R, Johnson KC, Salmon AG, Winder B, et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med. 2007;44(2):93–106.
Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2. Epub 2010/12/15.
International Agency for Research on Cancer, editor. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 83 -- Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC Press; 2004.
Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CWJ, et al. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87(11):1234–45.
Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens--Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033–4. Epub 2009/11/06.
Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiologic Reviews. 1993;15(1):145–56.
Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990;162(2):502–14.
MacMahon B, Trichopoulos D, Cole P, Brown J. Cigarette smoking and urinary estrogens. N Engl J Med. 1982;307(17):1062–5.
Hiatt RA, Fireman BH. Smoking, menopause, and breast cancer. J Natl Cancer Inst. 1986;76(5):833–8.
Terry PD, Rohan TE. Cigarette smoking and the risk of breast cancer in women: A review of the literature. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1):953–71.
Morabia A. Smoking (active and passive) and breast cancer: Epidemiologic evidence up to June 2001. Environ Mol Mutagen. 2002;39(2–3):89–95.
Wells AJ. Breast cancer, cigarette smoking, and passive smoking. Am J Epidemiol. 1991;133(2):208–10.
Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):5–73. Epub 1982/01/01.
Russo J, Russo IH. The etiopathogenesis of breast cancer prevention. Cancer Lett. 1995;90(1):81–9. Epub 1995/03/23.
IOM (Institute of Medicine). Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press; 2012.
DeRoo LA, Cummings P, Mueller BA. Smoking before a first pregnancy and the risk of breast cancer: a meta-analysis. Am J Epidemiol. 2011;174(4):390–402.
Luo J, Margolis K, Wactawski-Wende J, Horn K, Messina C, Stefanick M, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ. 2011;342:d1016. doi:10.1136/bmj.d1016.
Xue FWW, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125–33.
Cox DG. DL, Hunter DJ, Marchand LL, Hoover R, Ziegler RG, Thun MJ. N-acetyltransferase 2 polymorphisms, tobacco smoking and breast cancer in the breast and prostate cancer cohort consortiium. Am J Epidemiol. 2011;174(11):1316–22.
United States Public Health Service, Office of the Surgeon General, editor. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; 2006.
Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, et al. Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control. 2005;16(6):683–9.
Roddam AW, Pirie K, Pike MC, Chilvers C, Crossley B, Hermon C, et al. Active and passive smoking and the risk of breast cancer in women aged 36–45 years: a population based case–control study in the UK. Br J Cancer. 2007;97(3):434–9.
Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol. 2008;37(5):1069–79.
Reynolds P, Goldberg DE, Hurley S. Prevalence and patterns of environmental tobacco smoke exposures among California teachers. Am J Health Promot. 2004;18(5):358–65.
Reynolds P, Hurley SE, Hoggatt K, Anton-Culver H, Bernstein L, Deapen D, et al. Correlates of active and passive smoking in the California Teachers Study cohort. J Womens Health 2004;13(7):778–90. Epub 2004/09/24.
Windham GC, Bottomley C, Birner C, Fenster L. Age at menarche in relation to maternal use of tobacco, alcohol, coffee, and tea during pregnancy. Am J Epidemiol. 2004;159(9):862–71.
Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control. 2000;11(3):271–8.
Reynolds P, Goldberg D, Hurley S, Nelson DO, Largent J, Henderson KD, et al. Passive smoking and risk of breast cancer in the California teachers study. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3389–98.
Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol. 2000;152(3):226–32.
Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(1):15–26.
Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(4):602–11.
Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 123(3):877–83. Epub
Hein DW. N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol. 2009;5(4):353–66.
Anderson LN, Cotterchio M, Mirea L, Ozcelik H, Kreiger N. Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers. Am J Epidemiol. 2012;175(4):289–301.
Hein DW (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res. 506–507:65–77. Epub 2002/09/28.
Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic maine metabolism and carcinogenesis. Mutat Res. 2002;505–507:65–77.
Ochs-Balcom HM, Wiesner G, Elston RC. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. Am J Epidemiol. 2007;166(3):246–54.
Slattery ML, Curtin K, Giuliano AR, Sweeney C, Baumgartner R, Edwards S, et al. Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat. 2008;109(1):101–11.
Baumgartner KB, Schlierf TJ, Yang D, Doll MA, Hein DW. N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women. Toxicol Sci. 2009;112(1):211–20.
McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, et al. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect. 2009;117(4):552–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reynolds, P. Smoking and Breast Cancer. J Mammary Gland Biol Neoplasia 18, 15–23 (2013). https://doi.org/10.1007/s10911-012-9269-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10911-012-9269-x